The University of Colorado Rocky Mountain Alzheimer’s Disease Center at the CU Anschutz Medical Campus is garnering attention because of promising results from its research to treat Alzheimer’s. The CU Advocates program in the Office of the President along with the CU Forever Buffs Boulder Chapter on Sept. 13 are hosting a CU Scoop to spotlight research underway at CU that shows promise to treat Alzheimer's disease. A reception will follow.
You will learn from Dr. Huntington Potter who is leading the research. Tests of a drug currently on the market for other illnesses are raising hopes for a cure for Alzheimer's disease.
Huntington Potter, Ph.D. director, Rocky Mountain Alzheimer’s Disease Center at the CU Anschutz Medical Campus.
Dr. Potter says initial results from the safety trial of the drug Leukine® have not shown negative side effects that some other drugs have had. More tests are underway, and Dr. Potter says he is “cautiously optimistic” about the future of Alzheimer’s disease research. Denver’s NBC affiliate, 9News/KUSA, produced a three-part series about Alzheimer’s disease research called “New Hope for Alzheimer’s,” which includes interviews with researchers from CU's Rocky Mountain Alzheimer’s Disease Center and footage from Dr. Potter's lab. You can watch it by clicking here.